Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2019 Results – Earnings Call Transcript

 

Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2019 Results – Earnings Call Transcript

an essential step to regain compliance is the year two to do the reverse stock split in order to allow institutional investors and retail investors to bargain the marker in the market investors that …

More Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2019 Results – Earnings Call Transcript Videos

Leave a Reply